PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy

Recruiting

Phase 1

64Cu-GRIP BPET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy

Sponsor:

C. Babis Andreadis

Code:

NCT06522932

Conditions

Non Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

64Cu-GRIP B

Positron Emission Tomography (PET)

Optional tumor biopsy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-02. This information was provided to ClinicalTrials.gov by C. Babis Andreadis on 2025-06-08.